On ECHEMI
Home > Drugs > Fenbufen Capsules

Fenbufen Capsules

Function and Efficacy

This product is a long-acting non-steroidal anti-inflammatory drug. It can inhibit the activity of cyclooxygenase and reduce the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin. Results of acute toxicity tests: the oral LD50 of rats is 200-720 mg/kg, and the intraperitoneal injection LD50 is 265-575 mg/kg; the oral LD50 of mice is 795-1673 mg/kg, and the intraperitoneal injection LD50 is 506-811 mg/kg.

Ingredients

Fenbufen. Chemical name: 3-(4-biphenylcarbonyl) propionic acid Molecular weight: C16H14O3

Name Description Content CAS NO. Manufacturer
FenbufenIngredients

This product is a long-acting non-steroidal anti-inflammatory drug. It can inhibit the activity of cyclooxygenase and reduce the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin.

More
36330-85-5 9

Appearance

This product is a capsule, and the contents are white or off-white powder.

Indication

It is used to treat rheumatoid arthritis, rheumatic arthritis, osteoarthritis, spondyloarthropathies, and gouty arthritis. It can also be used for toothache, postoperative pain, and traumatic pain.

Usage and Dosage

Oral (1) Usual dosage for adults: 0.6 g per day, taken once or twice. The total daily dosage for adults should not exceed 1.0 g. (2) Usual dosage for children: Not yet established.

Adverse Reactions

The adverse reactions of this product are mainly gastrointestinal reactions, manifested as stomach pain, burning sensation in the stomach, nausea, and a few serious adverse reactions include gastric ulcer, bleeding, and even perforation. Dizziness, rash, mild decrease in white blood cell count, and mild increase in serum transferase are less common.

Precautions

1. Patients with known allergies to this product. 2. Patients who have asthma, urticaria or allergic reactions after taking aspirin or other non-steroidal anti-inflammatory drugs. 3. Contraindicated for the treatment of perioperative pain during coronary artery bypass grafting (CABG). 4. Patients with a history of gastrointestinal bleeding or perforation after the use of non-steroidal anti-inflammatory drugs. 5. Patients with active peptic ulcers/bleeding, or patients with recurrent ulcers/bleeding in the past. 6. Patients with severe heart failure.

Special Population Medication

Precautions for children: follow doctor's advice. Precautions for pregnancy and lactation: follow doctor's advice. Precautions for the elderly: Elderly patients should pay attention to renal toxicity due to decreased renal function.

Drug Interactions

Not yet clear.

Storage

Keep in a sealed container and away from light. Valid for 36 months.

Packaging Specification

0.15g

Validity Period

24 months

Manufacturer

Xiuzheng Pharmaceutical Group Co., Ltd.

  • Founded in:

    1999-03-29
  • Address:

    No. 36, Zhengxiu Road, Tonghua City, Jilin Province
  • Tax NO.:

    91220501244585084W
  • Registered Funds:

    50 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.